Evaluation of some antioxidant enzyme activities (SOD and GPX) and their polymorphisms (MnSOD2 Ala9Val, GPX1 Pro198Leu) in fibromyalgia

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 8, 2014, Pages 1199-1203

  Akbas, A ^a   Inanir, A ^a   Benli, I ^a   Onder, Y ^a   Aydogan, L ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Fibromyalgia; GPX; Oxidative stress; Polymorphism; SOD

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; ANTIOXIDANT;

ADULT; ALLELE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; FIBROMYALGIA; GENE FREQUENCY; GENOTYPE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL EXAMINATION; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PHENOTYPE; RISK FACTOR;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; FIBROMYALGIA; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; OXIDATIVE STRESS; PHENOTYPE; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 84902151414     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. GERDLE B, BJÖRK J, CÖSTER L, HENRIKSSON KG, HENRIKSSON C, BENGTSSON A. Prevalence of widespread pain and associations with work status: a population study. BMC Musculoskelet Disord 2008; 9: 102.
2. GÜR A. Fibromiyaljide Etiyopatogenez. Türk Fiz Tip Rehab Derg 2008; 54: 4-11. (Pubitemid 351836882)
3. RIVERA J, ALEGRE C, BALLINA FJ, CARBONELL J, CARMONA L, CASTEL B, COLLADO A, ESTEVE JJ, MARTÍNEZ FG, TORNERO J, VALLEJO MA, VIDAL J. Documento de consenso de la Sociedad Espanola de Reumatolog'a sobre la fibromialgia. Reumatol Clin 2006; 2: 55-66.
4. BELLATO E, MARINI E, CASTOLDI F, BARBASETTI N, MATTEI L, BONASIA DE, BLONNA D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012; 2012: 426130.
5. CORDERO MD. Oxidative stress in fibromyalgia: pathophysiology and clinical implications. Reumatol Clin 2011; 7: 281-283.
6. DIPLOCK AT. Antioxidants and disease prevention. Mol Aspects Med 1994; 15: 293-376. (Pubitemid 24289678)
7. MARKLUND SL. Analysis of extracellular superoxide dismutase in tissue homogenates and extracellular fluids. Methods Enzymol 1990; 186: 209-227
8. BATTIN EE, BRUMAGHIM JL. Antioxidant Activity of Sulfur and Selenium: A Review of Reactive Oxygen Species Scavenging, Glutathione Peroxidase, and Metal-Binding Antioxidant Mechanisms. Cell Biochem Biophys 2009; 55: 1-23.
9. ERMOLENKO NA, BOIARSKIKH UA, SUSHKO AG, VORONINA EN, SELEZNEVA IA, SINKINA TV, LAZAREV AF, PETROVA VD, FILIPENKO ML. Effect of point substitutions in the Mn-SOD, GPX1, and GSTP1 genes on the risk of familial and sporadic breast cancers in residents of the Altai region of the Russian Federation. Genetika 2010; 46: 1685-1691.
10. HU YJ, DIAMOND AM. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003; 63: 3347-3351. (Pubitemid 36735893)
11. WOLFE F, CATHEY MA. Prevalence of primary and secondary fibrositis. J Rheumatol 1983; 10: 965-968. (Pubitemid 14156292)
12. WOLFE F, ROSS K, ANDERSON J, RUSSELL IJ, HEBERT L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
13. TOPBAS M, CAKIRBAY H, GULEC H. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol 2005; 34: 140-144. (Pubitemid 40694834)
14. MÄKELÄ M, HELIÖVAARA M. Prevalence of primary fibromyalgia in the Finnish population. Br Med J 1991; 303: 216-219.
15. FAROOQI A, GIBSON T. Prevalence of the rheumatic disorders in the adult population of north Pakistan. Br J Rheumatol 1998; 37: 491-495.
16. AKKUS S, NAZIROGLU M, ERIS S, YALMAN K, YILMAZ N, YENER M. Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochem Funct 2009; 27: 181-185.
17. EISINGER J, ZAKARIAN H, POULY E, PLANTAMURA A, AYAVOU T. Protein peroxidation, magnesium deficiency and fibromyalgia. Magnes Res 1996; 9: 313-316.
18. CORDERO MD, ALCOCER-GÓMEZ E, CANO-GARCÍA FJ, DE MIGUEL M, CARRIÓN AM, NAVAS P, SÁNCHEZ ALCÁZAR JA. Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One 2011; 6: e26915.
19. NEYAL M, YIMENICIOGLU F, AYDENIZ A, TASKIN A, SAGLAM S, CEKMEN M, NEYAL A, GURSOY S, EREL O, BALAT A. Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg 2013; 115: 736-740.
20. BAGIS S, TAMER L, SAHIN G, BILGIN R, GULER H, ERCAN B, ERDOGAN C. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 2005; 25: 188-190. (Pubitemid 40576783)
21. OZGOCMEN S, OZYURT H, SOGUT S, AKYOL O, ARDICOGLU O, YILDIZHAN H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 2006; 26: 598-603.